Position in ROIV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$29,019
+$29,019 QoQ
Shares Held
820
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#390
of 494 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NOMURA ASSET MANAGEMENT CO LTD holds $211,753,525 across 66 Biotechnology names. ROIV ranks #21 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
120,235 | $59,724,331 | |
| 2 | ARGX |
Argenx SE
|
49,179 | $45,626,799 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
88,844 | $26,744,708 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,310 | $26,381,976 | |
| 5 | ASND |
Ascendis Pharma A/S
|
43,678 | $11,649,796 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
51,993 | $9,737,249 | |
| 7 | INCY |
Incyte Corp
|
84,470 | $9,575,518 | |
| 8 | RPRX |
Royalty Pharma plc
|
167,680 | $9,401,817 |
All Filings in ROIV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,019 | 820 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $0 | 0 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $47,740 | 2,200 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $33,286 | 2,200 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $24,794 | 2,200 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $22,198 | 2,200 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||